JUNS NASDAQ
Jupiter Neurosciences, Inc.
1W: -3.0%
1M: -24.5%
3M: -84.4%
YTD: -96.6%
1Y: -98.0%
$2.55
+0.05 (+2.00%)
Weekly Expected Move ±11.7%
$2
$2
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
9 relationships9
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-11-19
Earliest Filing
2026-02-20
Latest Filing
investor: 5
target: 4
Counterparties (Filed by JUNS)
9 relationshipsCompanies named in JUNS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. | JUNS | target | Company issuing convertible notes and entering into an omnibus amendment regarding repayment terms | 2026-02-20 | View |
| YA II PN, LTD. | — | investor | Investor holding convertible promissory notes and entering into an omnibus amendment | 2026-02-20 | View |
| YA II PN, LTD | — | investor | Investor entering Standby Equity Purchase Agreement to purchase common stock and receive convertible promissory notes. | 2025-12-23 | View |
| Jupiter Neurosciences, Inc. | JUNS | target | Company entering into Standby Equity Purchase Agreement | 2025-11-20 | View |
| YA II PN, Ltd. | — | investor | Investor entering into Standby Equity Purchase Agreement | 2025-11-20 | View |
| YA II PN, LTD. | — | investor | Investor in the Standby Equity Purchase Agreement | 2025-10-27 | View |
| JUPITER NEUROSCIENCES, INC. | JUNS | target | Company issuing shares to the Investor | 2025-10-27 | View |
| Puritan Partners LLC | — | investor | Investor entering into an amendment to delay payments on secured notes and shares. | 2024-11-19 | View |
| Jupiter Neurosciences, Inc. | JUNS | target | Company issuing notes and shares and amending terms with investor. | 2024-11-19 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-03 | Bylaws Amendment; Exhibits | View | |
| 2026-08-28 | Delisting Notice; Other Events; Exhibits | View | |
| 2026-08-27 | Material Agreement; Officer/Director Change; Other Events; Exhibits | Agreement | View |
| 2026-08-24 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-08-24 | Other Events; Exhibits | View | |
| 2026-08-06 | Bylaws Amendment; Other Events; Exhibits | View | |
| 2026-07-28 | Unregistered Equity Sales; Other Events; Exhibits | View | |
| 2026-07-27 | Shareholder Vote; Other Events; Exhibits | View | |
| 2026-07-21 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-06-30 | Officer/Director Change; Exhibits | View | |
| 2026-06-22 | Officer/Director Change; Exhibits | View | |
| 2026-06-05 | Officer/Director Change; Exhibits | View | |
| 2026-05-21 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-05-20 | Regulation FD; Other Events; Exhibits | View | |
| 2026-02-27 | Notice of Delisting or Transfer; Regulation FD Disclosure | View | |
| 2026-02-20 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-12-23 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-12-22 | Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or | View | |
| 2025-11-20 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-10-27 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR